Putting a price on long-term life insurance business

Allianz's Thomas Wilson re-examines how firms measure the value of capital-intensive products


Balancing earnings and capital is critical for managing the value of long-term life products. For these products, earnings emerge only over time – if at all – and depend on future market and insurance outcomes. In contrast, they cause a very concrete upfront capital strain.

Even more challenging for value managers, the value created by the expected earnings cannot be assessed without recognising the capital strain at an appropriate cost of capital: only earnings in excess of the cost of capital

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact [email protected] or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact [email protected] to find out more.

To continue reading...


You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here: